TwinBeech Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.6M Buy
+5,203
New +$1.61M 0.37% 87
2026
Q1
– Sell
-3,525
Closed -$884K – 716
2025
Q4
$884K Sell
3,525
-26,196
-88% -$6.96M 0.06% 319
2025
Q3
$8.53M Buy
+29,721
New +$7.96M 0.34% 93
2025
Q2
– Sell
-152,851
Closed -$35.6M – 845
2025
Q1
$35.6M Buy
+152,851
New +$37.1M 0.65% 40
2022
Q4
– Sell
-63,880
Closed -$11.2M – 826
2022
Q3
$11.2M Buy
+63,880
New +$13.1M 0.3% 102
2022
Q2
– Sell
-31,163
Closed -$7.06M – 619
2022
Q1
$7.06M Buy
+31,163
New +$7.33M 0.31% 95
2021
Q4
– Sell
-2,064
Closed -$499K – 699
2021
Q3
$499K Buy
+2,064
New +$520K 0.04% 432

Other funds holding LH

TwinBeech Capital's LH Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Labcorp (LH) in Q3 2026: 5,203 shares worth $1.6M. The stake represents 0.37% of the portfolio and ranks #87 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in LH as recently as Q4 2025.

TwinBeech Capital first reported a position in LH in Q3 2021 and has held it in 7 quarters since. The position peaked at $35.6M in Q1 2025. 1,089 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • TwinBeech Capital held 5,203 shares of Labcorp worth $1.6M as of Q3 2026.
  • Labcorp was a new TwinBeech Capital position in Q3 2026.
  • Labcorp made up 0.37% of TwinBeech Capital's portfolio in Q3 2026, its #87 holding.
  • TwinBeech Capital first reported a position in Labcorp in Q3 2021 and has held it in 7 quarters since.
  • TwinBeech Capital's Labcorp position peaked at $35.6M in Q1 2025.
  • 1,089 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.